Nextrials? Prism wins gold in the mobile star awards for health care data capture technology.
Nextrials’ Prism Wins Gold in the Mobile Star Awards for Healthcare Data Capture Technology
Prism selected as a top category winner in annual reader’s choice competition
San Ramon, CA – November 3, 2008
– Nextrials, Inc., a leader in clinical research software and services, today announced that its flagship electronic data capture and clinical trial management software, Prism®, captured a Gold Mobile Star Award™ from MobileVillage®, the 15-year leader in market development and news services about mobile technology. Prism was a winner in the enterprise software category for healthcare data capture.
Nextrials’ Prism is purpose-built for the pharmaceutical, medical device and biotechnology industries and melds sophisticated clinical trial management functionality with Electronic Data Capture (EDC) in a single, integrated package. It is currently used worldwide by pharmaceutical and biotechnology R&D teams developing novel treatments and therapeutics. Recently, Prism added support for remote access via the Apple® iPhone™, giving researchers anywhere/anytime access to ongoing clinical trial data.
“Despite the economic slowdown, recent studies have predicted minimal impact on the mobile and wireless industry,” said MobileVillage editor Gary Thayer. “People have fallen in love with mobile productivity and entertainment products, and there’s a real desire to discover and share the latest and greatest.”
The seventh annual Mobile Star Awards program honors the best companies, products, deployments and leaders in mobile and wireless technology. Winners are chosen by subscribers to Go Mobile®, MobileVillage’s free email newsletter for technology executives, mobile professionals, IT managers, developers and top tech journalists.
This year’s Mobile Star Awards winners are posted online at
http://www.mobilevillage.com/awards.htm
.
About MobileVillage®
Founded in 1993, MobileVillage is a market and solution development company dedicated to advancing mobile and wireless productivity in a wide range of industries. MobileVillage accomplishes this by fostering education and alliances through its Mobile "Best of Breed" solution identification, event partnerships, an online industry directory, industry job postings, daily online news, its widely respected Go Mobile® newsletter, a Mobile Mentors™ program, and popular annual Mobile Star Awards™ program. Visit MobileVillage online at www.mobilevillage.com <
http://www.mobilevillage.com
> .
About Nextrials, Inc.
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com <
http://www.nextrials.com
> or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at
http://pharmavoice.com/podcasts
.
MobileVillage®, Go Mobile®, Mobile Star Awards™ and Mobile Mentors™ are trademarks or registered trademarks of MobileVillage / PDA Inc.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.